Michael Ferguson
Director/Board Member chez NANOVIBRONIX, INC.
Fortune : - $ au 31/03/2024
Profil
Michael A.
Ferguson is the founder of Ferguson Strategies LLC, which was founded in 2009.
He held the title of Chairman & Chief Executive Officer from 2009 to 2016.
Currently, he is an Independent Director at NanoVibronix, Inc. since 2015 and a Director at Independent College Fund of New Jersey.
In the past, he served as Chairman-Commissioners Board at New Jersey Sports & Exposition Authority, Chairman at Ohr Pharmaceutical, Inc. from 2017 to 2019, Director at National Italian American Foundation, Inc., and Independent Director at Globis Acquisition Corp.
He also served as an Independent Director at Forafric Global Plc from 2020 to 2022.
Mr. Ferguson received his undergraduate degree from the University of Notre Dame and his graduate degree from Georgetown University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
NANOVIBRONIX, INC.
-.--% | 23/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michael Ferguson
Sociétés | Poste | Début |
---|---|---|
NANOVIBRONIX, INC. | Director/Board Member | 27/04/2015 |
Independent College Fund of New Jersey | Director/Board Member | - |
Anciens postes connus de Michael Ferguson
Sociétés | Poste | Fin |
---|---|---|
FORAFRIC GLOBAL PLC | Director/Board Member | 09/06/2022 |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Chairman | 12/07/2019 |
Ferguson Strategies LLC | Chief Executive Officer | 01/06/2016 |
GLOS ACQU | Director/Board Member | - |
New Jersey Sports & Exposition Authority | Chairman | - |
Formation de Michael Ferguson
University of Notre Dame | Undergraduate Degree |
Georgetown University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
NANOVIBRONIX, INC. | Health Technology |
FORAFRIC GLOBAL PLC | Process Industries |
Entreprise privées | 6 |
---|---|
National Italian American Foundation, Inc.
National Italian American Foundation, Inc. Investment Trusts/Mutual FundsMiscellaneous National Italian American Foundation (NIAF) provides education and careers to Italian Americans. It provides services through the development of educational programs, advocacy of representation in government, monitoring how Italians and Italian-Americans are depicted in the media and the forging of ties between the United States and Italy. the firm also offers scholarships for Italian-American students and for students emarking on Italian-based studies. NIAF was founded in 1975 and is headquartered at Washington, DC. | Miscellaneous |
New Jersey Sports & Exposition Authority | Government |
Independent College Fund of New Jersey | |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
Ferguson Strategies LLC | |
Globis Acquisition Corp.
Globis Acquisition Corp. Financial ConglomeratesFinance Globis Acquisition Corp. is a blank check company, which engages in seeking a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Paul Packer on August 21, 2020 and is headquartered in Boca Raton, FL. | Finance |